Revelation Biosciences REVB
NASDAQ REVB
$0.79 -0.01 (-0.93%)
As of: Oct 2, 2026 · 12:05 PM EDT

Revelation Biosciences (REVB) Long-Term Investments (2020 - 2021)

Updated

Revelation Biosciences (REVB) posted Long-Term Investments of $48.3 million for Q4 2021, down 34.3% from $73.51 million a year earlier and down 34.3% from the prior quarter.

Analysis

Revelation Biosciences (REVB) Long-Term Investments (2020 - 2021) Analysis & Trends

Since Q4 2020, Revelation Biosciences has reported Long-Term Investments for 5 quarters.

  • In prior years, Revelation Biosciences' Long-Term Investments was $73.51 million in FY2020.
  • According to Business Quant data, Long-Term Investments for the three prior quarters was $73.52 million (Q3 2021), $73.51 million (Q2 2021) and $73.51 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Revelation Biosciences 3.20 Mn -45.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 48.30 Mn
Sep 30, 2021 73.52 Mn
Jun 30, 2021 73.51 Mn
Mar 31, 2021 73.51 Mn
Dec 31, 2020 73.51 Mn
API Access

Revelation Biosciences Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=REVB&period=max&api_key=YOUR_API_KEY